Clinical Trials · NCT07483658
Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- CHU de Quebec-Universite Laval
- Enrollment
- 434
- Start date
- May 2026
- Locations
- 4 sites, Canada
- Primary endpoint
- Incidence of Grade 2 or Higher Genitourinary (GU) or Gastrointestinal (GI) Toxicity